Investment Thesis
MHV invests in UK-based health tech founders, enabling domestic growth in the UK while accelerating expansion into the US. The fund partners with NHS trusts and health systems to generate real-world evidence, facilitating broader adoption of portfolio solutions. Their value-added model aligns founders, patients, clinicians, and health systems from the outset.
Stage Focus
Adoption and scale (transatlantic growth)
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Clinical innovators and transformative health tech solutions
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€4,130,000 - €7,350,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (11)
A
Aditi Babel
Associate, Innovations in Mental Health
D
Daniel Dickens
Co-Managing Partner
D
Dr. Aditi Babel
Associate, Innovations in Mental Health
D
Dr. Nadine Haram
Co-Managing Partner
D
Dr. Patrik Bächtiger
Venture Partner, Meridian Health Ventures I
D
Dr. Pooja Sikka
General Partner
M
Madhav Mahendra
Principal, Meridian Health Ventures I
N
Nadine Haram
Co-Managing Partner
P
Patrik Bächtiger
Venture Partner, Meridian Health Ventures I
P
Pooja Sikka
General Partner
T
Tim Irish
General Partner